Active, not recruitingNo phase
Artificial Intelligence-assisted Diagnosis
Key facts
- Who runs it
- China National Center for Cardiovascular Diseases
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 60,000 people, planned
- Started
- 15 Jan 2025
- Expected to end
- 15 Jan 2030
- Type of study
- Observational, 2 groups
- Treatments tested
- surgical or interventional validation
- Record updated
- 14 July 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Chest X-ray of patients with ASD
- Chest X-ray of patients with VSD
- Chest X-ray of patients with PDA
- Chest X-ray of patients with PFO
- Chest X-ray of patients with PS
- Chest X-ray of patients with TOF/PAA
- Chest X-ray of patients with MS
- Chest X-ray of patients with other heart diseases
Who cannot take part
- CHD Patients without surgical, interventional validation
- Serious Scoliosis
- Pulmonary inflammation or consolidation
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate whether an AI-assisted decision support can improve the diagnosis of congenital heart diseases on Chest X-ray.
The 2 groups in the trial
- Previous data of chest X-ray in patients with CHD
Phase 1: Previous data of chest X-ray in patients with CHD. A minimum of 5000 patients is reached.
Treatment: surgical or interventional validation
- Prospective inclusion of general patients with chest X-ray
Prospective inclusion of general patients with chest X-ray. A minimum of 50000 patients is reached.
Treatment: surgical or interventional validation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Artificial Intelligence-assisted Diagnosis of Congenital Heart Diseases on Chest X-ray
- Record updated
- 14 July 2025